Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Validering af det patientadministrerede Danske Prostate Symptom Scoringsskema

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Isoniazidinduceret toksisk hepatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Epidemiologi, klinik og behandling af SARS-CoV-2 infektion hos børn

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Det danske screeningsprogram for hæmoglobinopatier

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Udredning og behandling af mandlig infertilitet

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Malignant pertussis in a three-week-old girl

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Towards a new paradigm in bladder pain syndrome and interstitial cystitis

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
The DAN-PSS-1 system, a self-administered quality-of-life questionnaire comprising 12 questions related to voiding problems and the perceived bother of each individual symptom, was compared to other extensively used score systems and furthermore included in different clinical situations so as to validate the system. The system was internally consistent (alpha cr = 0.73), the median test-retest reliability of answers to each question was 83.5% (range 0-99.7%). A high degree of construct validity demonstrated in the correlation with the Madsen-Iversen score system (rs = 0.51) and with the patients' answers to questions about how bothersome their symptoms were (rs = 0.71). The discriminant validity of the DAN-PSS-1 was excellent with an area under the ROC curve of 0.94. Finally, the DAN-PSS-1 was sensitive to changes following intervention, with scores decreasing 100% after transurethral prostatectomy and 65% after four months of treatment with an alpha-blocker. The DAN-PSS-1 is reliable, valid and responsive, and therefore can be recommended for assessing the severity of symptoms among patients presenting with lower urinary tract complaints suggestive of BPH and during follow-up.
Bidragets oversatte titelValidation of the patient-administered Danish Prostate Symptom Score Schedule
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind159
Udgave nummer5
Sider (fra-til)591-7
Antal sider7
ISSN0041-5782
StatusUdgivet - 27 jan. 1997

    Forskningsområder

  • Denmark, Evaluation Studies as Topic, Humans, Male, Prostatectomy, Prostatic Hyperplasia, Quality of Life, Questionnaires, Self Administration

ID: 38958461